Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Equity Ratio (2016 - 2025)

Editas Medicine (EDIT) has disclosed Equity Ratio for 11 consecutive years, with 0.07 as the latest value for Q3 2025.

  • Quarterly Equity Ratio fell 87.56% to 0.07 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.07 through Sep 2025, down 87.56% year-over-year, with the annual reading at 0.39 for FY2024, 43.79% down from the prior year.
  • Equity Ratio for Q3 2025 was 0.07 at Editas Medicine, down from 0.09 in the prior quarter.
  • The five-year high for Equity Ratio was 0.82 in Q1 2022, with the low at 0.07 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.62, with a median of 0.7 recorded in 2022.
  • The sharpest move saw Equity Ratio soared 62.69% in 2021, then tumbled 87.56% in 2025.
  • Over 5 years, Equity Ratio stood at 0.82 in 2021, then dropped by 14.19% to 0.7 in 2022, then fell by 0.27% to 0.7 in 2023, then crashed by 43.79% to 0.39 in 2024, then plummeted by 83.04% to 0.07 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.07, 0.09, and 0.24 for Q3 2025, Q2 2025, and Q1 2025 respectively.